期刊
ACS CENTRAL SCIENCE
卷 2, 期 7, 页码 476-482出版社
AMER CHEMICAL SOC
DOI: 10.1021/acscentsci.6b00150
关键词
-
资金
- Directorate For Engineering [1549133] Funding Source: National Science Foundation
- Div Of Industrial Innovation & Partnersh [1549133] Funding Source: National Science Foundation
The ability to activate drugs only at desired locations avoiding systemic immunosuppression and other dose limiting toxicities is highly desirable. Here we present a new approach, named local drug activation, that uses bioorthogonal chemistry to concentrate and activate systemic small molecules at a location of choice. This method is independent of endogenous cellular or environmental markers and only depends on the presence of a preimplanted biomaterial near a desired site (e.g., tumor). We demonstrate the clear therapeutic benefit with minimal side effects of this approach in mice over systemic therapy using a doxorubicin prodrug against xenograft tumors of a type of soft tissue sarcoma (HT1080).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据